Lysosomal Storage Diseases Market
1 Study Coverage
1.1 Lysosomal Storage Diseases Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lysosomal Storage Diseases Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lysosomal Storage Diseases Market Size for the Year 2017-2028
1.2.2 Global Lysosomal Storage Diseases Market Size for the Year 2017-2028
1.3 Lysosomal Storage Diseases Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lysosomal Storage Diseases in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lysosomal Storage Diseases Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lysosomal Storage Diseases Market Dynamics
1.4.1 Lysosomal Storage Diseases Industry Trends
1.4.2 Lysosomal Storage Diseases Market Drivers
1.4.3 Lysosomal Storage Diseases Market Challenges
1.4.4 Lysosomal Storage Diseases Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lysosomal Storage Diseases by Type
2.1 Lysosomal Storage Diseases Market Segment by Type
2.1.1 Enzyme Replacement Therapy
2.1.2 Substrate Reduction Therapy
2.1.3 Cystine Depleting Agents
2.2 Global Lysosomal Storage Diseases Market Size by Type (2017, 2022 & 2028)
2.3 Global Lysosomal Storage Diseases Market Size by Type (2017-2028)
2.4 United States Lysosomal Storage Diseases Market Size by Type (2017, 2022 & 2028)
2.5 United States Lysosomal Storage Diseases Market Size by Type (2017-2028)
3 Lysosomal Storage Diseases by Application
3.1 Lysosomal Storage Diseases Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.2 Global Lysosomal Storage Diseases Market Size by Application (2017, 2022 & 2028)
3.3 Global Lysosomal Storage Diseases Market Size by Application (2017-2028)
3.4 United States Lysosomal Storage Diseases Market Size by Application (2017, 2022 & 2028)
3.5 United States Lysosomal Storage Diseases Market Size by Application (2017-2028)
4 Global Lysosomal Storage Diseases Competitor Landscape by Company
4.1 Global Lysosomal Storage Diseases Market Size by Company
4.1.1 Top Global Lysosomal Storage Diseases Companies Ranked by Revenue (2021)
4.1.2 Global Lysosomal Storage Diseases Revenue by Player (2017-2022)
4.2 Global Lysosomal Storage Diseases Concentration Ratio (CR)
4.2.1 Lysosomal Storage Diseases Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lysosomal Storage Diseases in 2021
4.2.3 Global Lysosomal Storage Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lysosomal Storage Diseases Headquarters, Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lysosomal Storage Diseases Headquarters and Area Served
4.3.2 Global Lysosomal Storage Diseases Companies Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lysosomal Storage Diseases Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lysosomal Storage Diseases Market Size by Company
4.5.1 Top Lysosomal Storage Diseases Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lysosomal Storage Diseases Revenue by Players (2020, 2021 & 2022)
5 Global Lysosomal Storage Diseases Market Size by Region
5.1 Global Lysosomal Storage Diseases Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lysosomal Storage Diseases Market Size by Region (2017-2028)
5.2.1 Global Lysosomal Storage Diseases Market Size by Region: 2017-2022
5.2.2 Global Lysosomal Storage Diseases Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lysosomal Storage Diseases Market Size YoY Growth 2017-2028
6.1.2 North America Lysosomal Storage Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lysosomal Storage Diseases Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lysosomal Storage Diseases Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Lysosomal Storage Diseases Market Size YoY Growth 2017-2028
6.3.2 Europe Lysosomal Storage Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lysosomal Storage Diseases Market Size YoY Growth 2017-2028
6.4.2 Latin America Lysosomal Storage Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lysosomal Storage Diseases Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lysosomal Storage Diseases Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Actelion Pharmaceuticals
7.1.1 Actelion Pharmaceuticals Company Details
7.1.2 Actelion Pharmaceuticals Business Overview
7.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Introduction
7.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.1.5 Actelion Pharmaceuticals Recent Development
7.2 BioMarin
7.2.1 BioMarin Company Details
7.2.2 BioMarin Business Overview
7.2.3 BioMarin Lysosomal Storage Diseases Introduction
7.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.2.5 BioMarin Recent Development
7.3 Genzyme
7.3.1 Genzyme Company Details
7.3.2 Genzyme Business Overview
7.3.3 Genzyme Lysosomal Storage Diseases Introduction
7.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.3.5 Genzyme Recent Development
7.4 Takeda
7.4.1 Takeda Company Details
7.4.2 Takeda Business Overview
7.4.3 Takeda Lysosomal Storage Diseases Introduction
7.4.4 Takeda Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.4.5 Takeda Recent Development
7.5 Alexion Pharmaceuticals
7.5.1 Alexion Pharmaceuticals Company Details
7.5.2 Alexion Pharmaceuticals Business Overview
7.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Introduction
7.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.5.5 Alexion Pharmaceuticals Recent Development
7.6 Amicus Therapeutics
7.6.1 Amicus Therapeutics Company Details
7.6.2 Amicus Therapeutics Business Overview
7.6.3 Amicus Therapeutics Lysosomal Storage Diseases Introduction
7.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.6.5 Amicus Therapeutics Recent Development
7.7 Chiesi Farmaceutici
7.7.1 Chiesi Farmaceutici Company Details
7.7.2 Chiesi Farmaceutici Business Overview
7.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Introduction
7.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.7.5 Chiesi Farmaceutici Recent Development
7.8 Greenovation Biotech And FGK Clinical Research
7.8.1 Greenovation Biotech And FGK Clinical Research Company Details
7.8.2 Greenovation Biotech And FGK Clinical Research Business Overview
7.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Introduction
7.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.8.5 Greenovation Biotech And FGK Clinical Research Recent Development
7.9 Horizon Pharma
7.9.1 Horizon Pharma Company Details
7.9.2 Horizon Pharma Business Overview
7.9.3 Horizon Pharma Lysosomal Storage Diseases Introduction
7.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.9.5 Horizon Pharma Recent Development
7.10 Leadiant Biosciences
7.10.1 Leadiant Biosciences Company Details
7.10.2 Leadiant Biosciences Business Overview
7.10.3 Leadiant Biosciences Lysosomal Storage Diseases Introduction
7.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.10.5 Leadiant Biosciences Recent Development
7.11 Mylan
7.11.1 Mylan Company Details
7.11.2 Mylan Business Overview
7.11.3 Mylan Lysosomal Storage Diseases Introduction
7.11.4 Mylan Revenue in Lysosomal Storage Diseases Business (2017-2022)
7.11.5 Mylan Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Lysosomal Storage Diseases Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Lysosomal Storage Diseases Market Trends
Table 3. Lysosomal Storage Diseases Market Drivers
Table 4. Lysosomal Storage Diseases Market Challenges
Table 5. Lysosomal Storage Diseases Market Restraints
Table 6. Global Lysosomal Storage Diseases Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Lysosomal Storage Diseases Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Lysosomal Storage Diseases Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Lysosomal Storage Diseases Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Lysosomal Storage Diseases Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Lysosomal Storage Diseases Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Lysosomal Storage Diseases Revenue Share by Player, 2017-2022
Table 13. Global Lysosomal Storage Diseases Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lysosomal Storage Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2021)
Table 15. Top Players of Lysosomal Storage Diseases in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Lysosomal Storage Diseases Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Lysosomal Storage Diseases Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Lysosomal Storage Diseases Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Lysosomal Storage Diseases Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Lysosomal Storage Diseases Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Lysosomal Storage Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Lysosomal Storage Diseases Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Lysosomal Storage Diseases Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Lysosomal Storage Diseases Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Lysosomal Storage Diseases Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Lysosomal Storage Diseases Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Lysosomal Storage Diseases Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Actelion Pharmaceuticals Company Details
Table 31. Actelion Pharmaceuticals Business Overview
Table 32. Actelion Pharmaceuticals Lysosomal Storage Diseases Product
Table 33. Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 34. Actelion Pharmaceuticals Recent Development
Table 35. BioMarin Company Details
Table 36. BioMarin Business Overview
Table 37. BioMarin Lysosomal Storage Diseases Product
Table 38. BioMarin Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 39. BioMarin Recent Development
Table 40. Genzyme Company Details
Table 41. Genzyme Business Overview
Table 42. Genzyme Lysosomal Storage Diseases Product
Table 43. Genzyme Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 44. Genzyme Recent Development
Table 45. Takeda Company Details
Table 46. Takeda Business Overview
Table 47. Takeda Lysosomal Storage Diseases Product
Table 48. Takeda Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 49. Takeda Recent Development
Table 50. Alexion Pharmaceuticals Company Details
Table 51. Alexion Pharmaceuticals Business Overview
Table 52. Alexion Pharmaceuticals Lysosomal Storage Diseases Product
Table 53. Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 54. Alexion Pharmaceuticals Recent Development
Table 55. Amicus Therapeutics Company Details
Table 56. Amicus Therapeutics Business Overview
Table 57. Amicus Therapeutics Lysosomal Storage Diseases Product
Table 58. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 59. Amicus Therapeutics Recent Development
Table 60. Chiesi Farmaceutici Company Details
Table 61. Chiesi Farmaceutici Business Overview
Table 62. Chiesi Farmaceutici Lysosomal Storage Diseases Product
Table 63. Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 64. Chiesi Farmaceutici Recent Development
Table 65. Greenovation Biotech And FGK Clinical Research Company Details
Table 66. Greenovation Biotech And FGK Clinical Research Business Overview
Table 67. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Product
Table 68. Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 69. Greenovation Biotech And FGK Clinical Research Recent Development
Table 70. Horizon Pharma Company Details
Table 71. Horizon Pharma Business Overview
Table 72. Horizon Pharma Lysosomal Storage Diseases Product
Table 73. Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 74. Horizon Pharma Recent Development
Table 75. Leadiant Biosciences Company Details
Table 76. Leadiant Biosciences Business Overview
Table 77. Leadiant Biosciences Lysosomal Storage Diseases Product
Table 78. Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 79. Leadiant Biosciences Recent Development
Table 80. Mylan Company Details
Table 81. Mylan Business Overview
Table 82. Mylan Lysosomal Storage Diseases Product
Table 83. Mylan Revenue in Lysosomal Storage Diseases Business (2017-2022) & (US$ Million)
Table 84. Mylan Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Lysosomal Storage Diseases Product Picture
Figure 2. Global Lysosomal Storage Diseases Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Lysosomal Storage Diseases Market Size 2017-2028 (US$ Million)
Figure 4. United States Lysosomal Storage Diseases Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Lysosomal Storage Diseases Market Size 2017-2028 (US$ Million)
Figure 6. United States Lysosomal Storage Diseases Market Share in Global 2017-2028
Figure 7. Lysosomal Storage Diseases Report Years Considered
Figure 8. Product Picture of Enzyme Replacement Therapy
Figure 9. Product Picture of Substrate Reduction Therapy
Figure 10. Product Picture of Cystine Depleting Agents
Figure 11. Global Lysosomal Storage Diseases Market Share by Type in 2022 & 2028
Figure 12. Global Lysosomal Storage Diseases Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Lysosomal Storage Diseases Market Share by Type (2017-2028)
Figure 14. United States Lysosomal Storage Diseases Market Share by Type in 2022 & 2028
Figure 15. United States Lysosomal Storage Diseases Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Lysosomal Storage Diseases Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Ambulatory Surgical Centers
Figure 19. Global Lysosomal Storage Diseases Market Share by Application in 2022 & 2028
Figure 20. Global Lysosomal Storage Diseases Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Lysosomal Storage Diseases Market Share by Application (2017-2028)
Figure 22. United States Lysosomal Storage Diseases Market Share by Application in 2022 & 2028
Figure 23. United States Lysosomal Storage Diseases Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Lysosomal Storage Diseases Market Share by Application (2017-2028)
Figure 25. North America Lysosomal Storage Diseases Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Lysosomal Storage Diseases Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Lysosomal Storage Diseases Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Lysosomal Storage Diseases Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Lysosomal Storage Diseases Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Lysosomal Storage Diseases Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 54. BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 55. Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 56. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 57. Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 58. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 59. Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 60. Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 61. Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 62. Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 63. Mylan Revenue Growth Rate in Lysosomal Storage Diseases Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Industry Market Size
